Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma
deposit · 1 version · 2 papers
Tumour and non-tumour liver proteomes from early-stage hepatocellular carcinoma patients (Jiang et al., Nature 2019), deposited at iProX. Named after the study, because iProX returns no title; pi-PrimeNovo evaluates on it as HCC.
| Kind | deposit |
| Organisms | Homo sapiens |
Tumour and non-tumour liver proteomes from early-stage hepatocellular carcinoma patients (Jiang et al., Nature 2019), deposited at iProX. Named after the study, because iProX returns no title; pi-PrimeNovo evaluates on it as HCC.
Versions
as deposited
Where it lives:
- iProX · IPX0000937000
Used by (2)
- π-PrimeNovo: an accurate and efficient non-autoregressive deep learning model for de novo peptide sequencing (2025) peer-reviewed as deposited
- π-PrimeNovo: an accurate and efficient non-autoregressive deep learning model for de novo peptide sequencing (2024) preprint as deposited
Methods on these papers (1)
- π-PrimeNovo algorithm
Taken from the describing links only, so a paper that merely ran a tool on this data does not make that tool a method of it.